维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Debruyne C"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅲ study of BEC2/BCG vaccinatio in limited disease small cell lung cancer(LD-SCLC) patients, following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study)显示文摘	Giaccone G Debruyne C Felip F	2004	J Clin Oncol2004，22，14：	1
2	Randomized study of paclitaxel cisplatin versus cisplatin-teniposide in patients with advanced non-small cell lung cancer 显示文摘	Splinte TAW Debruyne C	1998	J Clin Oncol1998，16，6：	1
3	Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)显示文摘	Giaccone G Debruyne C Felip E	2005	J Clin Oncol2005，23，28：	1
4	Immunotherapy in the landscape of new targeted treatments for non-smal cel lung cancer显示文摘	Gérard C Debruyne C		0，，5：	1
5	Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study) 显示文摘	Giaccone G Debruyne C Felip E	2005	J Clin Oncol2005，23，28：	1
6	European organizationfor research and treatment of cancer (EORTC) 08957 phase Ⅱ study of topotecan in combination with cisplatin as secondline treatment of refractory and sensitive small cell lung cancer显示文摘	Ardizzoni A Manegold C Debruyne C	2003	Clin Cancer Res2003，9，1：	1
7	Randomized study of paclitaxel-cisplatin versus cisplatin-tenigoside in patients with advanced non-small-cell lung cancer:the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group显示文摘	Giaccone G Splinter TA Debruyne C	1998	J Clin Onco11998，16，：	1
8	Patterns of bioaccumulation of polybrominated diphenyl ether and polychlorinated biphenyl congeners in marine mussels 显示文摘	Debruyn A M H Meloche L M Lowe C J	2009	Environ Sci Technol2009，43，10：	1
9	The importance of benthos in weight of evidence sediment assessments-A ease study显示文摘	Mepherson C Chapman P M Debruyn A M H	2008	Science of the Total Environment2008，394，23：	1
10	FDG uptake by the bone marrow in NSCLC patients is related toTGF,but not to VEGF or G-CSF serum levels显示文摘	VAN DE WIELE C VANDE VYVER F DEBRUYNE C	2008	J Nucl Med Mol Imaging2008，35，3：	1
11	PhaseⅢstudy of adjuvant vaccination with Bec2/bacille Calmette- Guerin in responding patients with Limited-disease small- cell lung cancer(European Organization for Research and Treatment of Cancer 08971- 08971B;Silva Study)显示文摘	GIACCONE G DEBRUYNE C FELIP E	2005	J Clin Oncol2005，23，28：	1
12	Symptom and quality of life results of an international randomised phase llI study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer 显示文摘	Bottomley A Debruyne C Felip E	2008	Eur J Cancer2008，44，15：	1
13	Phase Ⅲ study of adjuvant vaccination with Bec2/hacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer 显示文摘	Giaccone G Debruyne C Felip E	2005	J Clin Oncol2005，23，36：	1
14	European or- ganization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensi- tive small cell lung cancer 显示文摘	Ardizzoni A Manegold C Debruyne C	2003	Clin Cancer Res2003，9，1：	1
15	European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer显示文摘	Ardizzoni A Manegold C Debruyne C	2003	Clin Cancer Res2003，9，1：	1
16	Phase Ⅲ study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treat- ment of Cancer 08971-08971B;Silva Study)显示文摘	Giaccone G Debruyne C Felip E	2005	J Clin Oncol2005，23，28：	1
17	Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding pa-tients with limited-disease small-cell lung cancer (European Organi-sation for Research and Treatment of Cancer 08971-08971B; Silva Study)显示文摘	Giaccone G Debruyne C Felip E	2005	J Clin Oncol2005，23，28：	1
18	Symptom and quality of life results of an international randomised phase Ⅲ study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer显示文摘	Boomley A Debruyne C Felip E	2008	Eur J Cancer2008，44，15：	1
19	European organization for research and treatment of cancer ( EORTC ) 08957 phase Ⅱ study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer显示文摘	Ardizzoni A Manegold C Debruyne C	2003	Clin Cancer Res2003，9，：	1
20	European organization for research and treatment of cancer (EORTC) 08957 phase Ⅱ study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer显示文摘	Ardizzoni A Manegold C Debruyne C	2003	Clin Cancer Res2003，9，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示